Invicta Diagnostic Limited Acquires Majority Stake in Vinchurkar Diagnostics to Expand in Nashik

Invicta Diagnostic Limited Acquires Majority Stake in Vinchurkar Diagnostics to Expand in Nashik​

Invicta Diagnostic Limited, a prominent diagnostic service provider in Maharashtra's healthcare sector, announced its expansion beyond the Mumbai Metropolitan Region. The company confirmed the board's approval for the acquisition of a majority stake in Vinchurkar Diagnostics Private Limited, a well-established diagnostic services provider located in Nashik.

The acquisition of Vinchurkar Diagnostics Private Limited, established in 1993, aims to bolster Invicta Diagnostic Limited's regional footprint and supports its strategy to expand its diagnostic network across Maharashtra.

Acquisition Structure and Timeline​

The Company plans to acquire up to 95% equity stake in Vinchurkar Diagnostics Private Limited through two tranches. The transaction involves a total consideration of ₹ 7.60 Cr and will be settled via cash consideration.

The share acquisition is structured as follows:

• First Tranche: Acquisition of 51% shareholding by May 31, 2026.
• Second Tranche: Acquisition of up to 44% shareholding by October 31, 2026.

Details on Vinchurkar Diagnostics Private Limited​

Vinchurkar Diagnostics Private Limited offers a comprehensive range of diagnostic services including CT, MRI, mammography, and other diagnostic tests, and operates with a 24/7 service capability. It has a notable history in the region, being the first private diagnostic center in Nashik to introduce CT and Mammography in 1995, followed by MRI in 1999 and Superconducting MRI in 2004.

For the financial year 25, Vinchurkar Diagnostics reported a turnover of ₹ 4.45 Cr.

Financial Overview of Invicta Diagnostic Limited​

Invicta Diagnostic Limited, which operates under the PC Diagnostics brand in the Mumbai Metropolitan Region, reported specific financial metrics for FY25. The company recorded a consolidated revenue of ₹ 30.10 Cr, an EBITDA of ₹ 9.57 Cr, and a net profit of ₹ 4.69 Cr for FY25.

Invicta Diagnostic Limited operates through a network that includes seven diagnostic centers and one centralized laboratory across the MMR region. The company provides services such as radiology and imaging, pathology and clinical laboratory testing, and teleradiology.

Chairman and Non-Executive Director Mr. Sanket Vinod Jain stated that the acquisition aligns with the company's strategy to strengthen its presence in key markets across Maharashtra, noting that Nashik is a high-potential healthcare market.

INVICTA Stock Price Movement​

On Friday, Invicta Diagnostic Limited shares rallied to close at ₹75.00, marking a significant 2.74% advance for the session. The stock settled on 8,000 shares traded throughout the day.

Source:​